Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels

Authors:
  • ETElena Toschi
    Elena Toschi
  • SBStephanie Baldeweg
    Stephanie Baldeweg
  • ACArturo Casolaro
    Arturo Casolaro
  • SBSimona Baldi
    Simona Baldi
  • ASAnna Maria Sironi
    Anna Maria Sironi
  • JYJohn S. Yudkin
    John S. Yudkin
  • EFEle Ferrannini
    Ele Ferrannini

Abstract
Aims In conditions such as type 2 diabetes, hypertension, and smoking, in which haematocrit (Hct) tends to be higher, endothelial function is impaired. In vitro, haemoglobin neutralizes nitric oxide very effectively. Whether red blood cells participate in the regulation of endothelial function in vivo has not been established. Methods and results Clinical and haematological parameters and forearm blood flow responses to acetylcholine (ACh) and sodium nitroprusside (SNP) were measured in 84 type 2 diabetic patients and 19 control subjects. Diabetics showed blunted dose–response curves to both SNP and ACh. In diabetics, across quartiles of Hct, ACh blood flow responses were progressively lower (881±96, 652±81, 513±54, 307±46%, PP=0.06) despite similar age, body mass index, glycated haemoglobin (HbA1c), blood pressure, serum total and HDL-cholesterol levels, indices of insulin sensitivity, and markers of inflammation. After normalizing the ACh response for the SNP response (ACh/SNP ratio), a progressive reduction across Hct quartiles (1.54±0.23, 1.22±0.15, 0.93±0.09, 0.66±0.09, Pr=−0.46 and r=−0.66, respectively, PConclusion Both in diabetics and non-diabetics, haematocrit is inversely related to small vessel endothelium-dependent dilatation. Thus, in addition to blood rheology, a direct negative effect on nitric oxide availability might explain the link between high Hct and cardiovascular disease.